CAMPSQ3373
Title : Gallidermin
Source : Staphylococcus gallinarum (F16/P57) Tu3928, Staphylococcus cohnii T
Taxonomy : Bacteria
UniProt: P21838
PubMed : 3181159
Length : 22
Activity : Antibacterial
Gram Nature : Gram+ve, Gram-ve
Target : Staphylococcus aureus SG 511 ( MIC = 4 microg/ml ), Staphyloccous aureus E 88 ( MIC = 8 microg/ml ),Staphylococcus epidermidis ATCC 12228 ( MIC = 4 microg/ml ), Staphylococcus pneumoniae ATCC 6302 ( MIC = 4 microg/ml ), Streptococcus pyogenes ATCC 8668 ( MIC = 1 microg/ml ), Streptococcus faecalis ATCC 29212 ( MIC = 64 microg/ml ),Corynebacterium xerosis ATCC 9755 ( MIC = 1 microg/ml ),Escherichia coli ATCC 11 775 ( MIC = 128 microg/ml ),Pseudomonas aeruginosa BC 19 ( MIC = 128 microg/ml ), Micrococcus luteus ATCC 9341 ( MIC = 0.25 microg/ml ), Micrococcus luteus 15957 ( MIC = 0.5 microg/ml ), Bacillus fragilis (Bonn) ( MIC = 128 microg/ml ),Bacillus fragilis (Koln) ( MIC = 128 microg/ml ), Peptostreptococcus anaerobicus ( MIC = 0.5 microg/ml ), Propionibacterium acnes IF 31002 ( MIC = 0.125 microg/ml )
Validated : Experimentally Validated
Pfam : PF02052 : ( Gallidermin )
InterPro : IPR006078 : Gallidermin.
IPR006079 : Lan.
AMP Family : Bacteriocin
Gene Ontology :
GO ID Ontology Definition
Evidence
GO:0019835 Biological Process Cytolysis IEA
GO:0050830 Biological Process Defense response to Gram-positive bacterium IEA
Sequence:
IASKFLCTPGCAKTGSFNSYCC